Possible treatment targets, outcome measures, and more in progressive multiple sclerosis clinical trials
In a peer-reviewed International Pharmaceutical Industry article, Tomislav Babic discusses biomarkers, clinical outcome measures, study design, and more for progressive multiple sclerosis.
